Drug Trial Radar · NCT03168321
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)
Last checked: Nov 19, 2026Latest source record: Apr 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
813
Actual
Start
Jun 29, 2017
Primary completion
Jun 7, 2018
Study completion Jun 7, 2018
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 30, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion in comparison with IDP-123 Vehicle Lotion.
Conditions
- Acne Vulgaris
Interventions
IDP-123 LotionDrug
Tazarotene 0.045% Lotion
IDP-123 Vehicle LotionDrug
Vehicle Lotion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change in Mean Lesion Counts at Week 12Time frame: Baseline to Week 12
- Percentage of Subjects Who Had at Least a 2-grade Reduction From Baseline at Week 12 in the Evaluator's Global Severity Score (EGSS) and Had an EGSS at Week 12 That Equated to "Clear" or "Almost Clear"Time frame: Baseline to Week 12
Locations
45 sites in 2 countries. Site status is shown where the registry gives one.
Valeant Site 19
Phoenix, Arizona
Valeant Site 21
Phoenix, Arizona
Valeant Site 24
Hot Springs, Arkansas
Valeant Site 04
La Mesa, California
Valeant Site 02
Manhattan Beach, California
Valeant Site 42
Murrieta, California
Valeant Site 39
Sacramento, California
Valeant Site 01
San Diego, California
Valeant Site 37
Wheat Ridge, Colorado
Valeant Site 35
Boca Raton, Florida
Valeant Site 40
North Miami Beach, Florida
Valeant Site 33
Ormond Beach, Florida
Valeant Site 27
Pembroke Pines, Florida
Valeant Site 13
Sanford, Florida
Valeant Site 03
West Palm Beach, Florida
Valeant Site 26
Newnan, Georgia
Valeant Site 30
Boise, Idaho
Valeant Site 06
Arlington Heights, Illinois
Valeant Site 23
New Albany, Indiana
Valeant Site 17
South Bend, Indiana
Valeant Site 31
Overland Park, Kansas
Valeant Site 22
Louisville, Kentucky
Valeant Site 08
Metairie, Louisiana
Valeant Site 38
Detroit, Michigan
Valeant Site 16
Warren, Michigan
Valeant site 20
New York, New York
Valeant Site 36
New York, New York
Valeant Site 09
High Point, North Carolina
Valeant Site 32
Cincinnati, Ohio
Valeant Site 11
Dublin, Ohio
valeant Site 07
Gresham, Oregon
Valeant Site 15
Johnston, Rhode Island
Valeant Site 34
Knoxville, Tennessee
valeant Site 14
Nashville, Tennessee
Valeant Site 12
Austin, Texas
Valeant Site 05
Katy, Texas
Valeant Site 18
Plano, Texas
Valeant Site 25
San Antonio, Texas
Valeant Site 43
Webster, Texas
Valeant Site 41
Salt Lake City, Utah
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.